Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+31.2%
5Y CAGR-40.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+31.2%/yr
Quarterly compound
5Y CAGR
-40.8%/yr
Recent acceleration
Percentile
P95
Near historical high
vs 5Y Ago
0.1x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 141.34% |
| Q3 2025 | 61.28% |
| Q2 2025 | 57.14% |
| Q1 2025 | -20669.42% |
| Q4 2024 | 97.77% |
| Q3 2024 | 15.21% |
| Q2 2024 | 26.16% |
| Q1 2024 | -18.88% |
| Q4 2023 | -11.14% |
| Q3 2023 | 18.72% |
| Q2 2023 | 69.64% |
| Q1 2023 | -618.96% |
| Q4 2022 | 62.57% |
| Q3 2022 | -288.05% |
| Q2 2022 | 20.20% |
| Q1 2022 | -220.41% |
| Q4 2021 | 65.00% |
| Q3 2021 | 42.12% |
| Q2 2021 | 267.81% |
| Q1 2021 | -117.35% |
| Q4 2020 | 1949.55% |
| Q3 2020 | 91.62% |
| Q2 2020 | 11.32% |
| Q1 2020 | -733.36% |
| Q4 2019 | 135.69% |
| Q3 2019 | -221.93% |
| Q2 2019 | 83.04% |
| Q1 2019 | -2063.75% |
| Q4 2018 | 103.56% |
| Q3 2018 | -12.23% |
| Q2 2018 | 9.61% |
| Q1 2018 | -61.61% |
| Q4 2017 | 27.23% |
| Q3 2017 | 30.58% |
| Q2 2017 | 10.64% |
| Q1 2017 | -59.04% |
| Q4 2016 | 53.03% |
| Q3 2016 | -66.62% |
| Q2 2016 | 11.36% |
| Q1 2016 | -71.46% |